News | February 20, 2025
Innocan Pharma granted first patent in India for its Liposomal CBD Injection
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
IMCD India’s innovative formulations bring the Skinification trend to life with cutting-edge solutions across beauty and personal care
This Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability
Glenmark’s consolidated revenue was at Rs. 3,387.6 crore as against Rs. 2,506.7 crore recording an increase of 35.1% YoY
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Next-generation lens features purely refractive design, delivering uninterrupted high-quality vision with high best-in-category contrast & low-light performance
Plans underway to expand screening capacity by 50% for greater accessibility
The company anticipates 2025 worldwide sales to be between $64.1 billion and $65.6 billion
Branded formulation business continues to perform well across domestic and export markets
Subscribe To Our Newsletter & Stay Updated
